The present invention is directed to a method of identifying compounds that activate an mGluR2 receptor and are useful in the treatment of neuopsychological disorders, such as schizophrenia, anxiety, panic disorder, and drug withdrawal.
Method for identifying metabotropic glutamate receptor agonists and potentiators